Skip to main content
SpringerLink
Log in

Tuberculosis in Immunocompromised Hosts

  • Chapter
  • First Online:
Challenging Cases in Pulmonology

  • 1067 Accesses

Abstract

The diagnosis and treatment of tuberculosis in immunocompromised patients is often challenging. Although HIV infection is the greatest risk factor for TB; there are a growing number of cases of TB in patients on immunosuppressive therapy. Here we present two challenging cases of tuberculosis in immunocompromised hosts.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 189.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis ­following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158(1):157–61.

    PubMed  CAS  Google Scholar 

  2. Lawn SD, Myer L, Bekker LG, Wood R. Tuberculosis-associated immune reconstitution ­disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS. 2007;21(3):335–41.

    Article  PubMed  Google Scholar 

  3. Centers for Disease Control and Prevention (CDC). TB and HIV Coinfection. 2011. http://www.cdc.gov/tb/topic/TBHIVcoinfection/default.htm. Accessed 12 Feb 2011.

  4. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 10, 2011; 1–166. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.

  5. CDC. Managing drug interactions in the treatment of HIV-related tuberculosis. Division of Tuberculosis Elimination (DTBE). 2007. Available at: http://www.cdc.gov/tb/publications/guidelines/TB_HIV_Drugs/PDF/tbhiv.pdf. Accessed 12 Feb 2011.

  6. CDC. Treatment of tuberculosis, American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR Recomm Rep. 2003;52(RR-11):1–77.

    Google Scholar 

  7. CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMW R Recomm Rep. 2000;49(RR-6):1–51. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4906a1.htm.

  8. Study of latent tuberculosis infection in immunosuppressed rheumatology patients with an interferon-gamma release assay. Am J Respir Crit Care Med. 2008;177:A786.

    Google Scholar 

  9. Furst D, Keystone E, Fleischmann R, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. Ann Rheum Dis. 2010;69(Suppl I):2–29. doi:doi:10.1136/ard.2009.123885.

    Article  Google Scholar 

  10. Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection United States. MMRW. 2010;59(RR-5):1–25.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Rheumatology, University of Southern California, Keck School of Medicine, 2011 Zonal Avenue HMR 711, Los Angeles, CA, 90033, USA

    Stratos Christianakis M.D.

  2. Department of Internal Medicine, Kaiser Los Angeles Medical Center, Los Angeles, CA, USA

    Josh Banerjee M.D., MPH

  3. Department of Medicine, UCLA Medical Center, Santa Monica, CA, USA

    James S. Kim M.D.

  4. Department of Medicine, Division of Infectious Diseases, University of Southern California, Keck School of Medicine, 1300 N. Mission Road, Room 349, Los Angeles, CA, 90033, USA

    Brenda E. Jones M.D.

Authors
  1. Stratos Christianakis M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Josh Banerjee M.D., MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James S. Kim M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brenda E. Jones M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Stratos Christianakis M.D. or Brenda E. Jones M.D. .

Editor information

Editors and Affiliations

  1. Department of Medicine, University of California, San Francisco, 812 Pollard Rd. Suite #5, Los Gatos, 95032, California, USA

    Massoud Mahmoudi

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Christianakis, S., Banerjee, J., Kim, J.S., Jones, B.E. (2012). Tuberculosis in Immunocompromised Hosts. In: Mahmoudi, M. (eds) Challenging Cases in Pulmonology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7098-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-7098-5_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-7097-8

  • Online ISBN: 978-1-4419-7098-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation